Novavax Sets Out Vaccine Strategy For New COVID-19 Variants
Share Price Wobbles On Filing Uncertainty
The US company is poised to file with regulators in Q2, but is also looking for longer-term competitive advantage in its variant strategy.
The US company is poised to file with regulators in Q2, but is also looking for longer-term competitive advantage in its variant strategy.